NovoThelium
San Antonio
About NovoThelium
NovoThelium is a biotechnology company developing a tissue-engineered nipple matrix for use in breast reconstruction. NovoThelium was founded in 2015 by biomedical engineers with family histories of breast cancer to work on nipple regeneration after mastectomy. NovoThelium is developing a bioengineered matrix that enables patients to regenerate a nipple made from their own cells that maintains projection, has natural pigmentation, and improved sensation.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $82.0K
- Last round: Grant (May 2020)
- Website: novothelium.com
- Phone: 210-582-5890
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/novothelium-65707 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.